News
CRISPR-engineered T cells may be safe for cancer, but do they work?
All three patients who received CRISPR-engineered T cells in a phase 1 trial experienced cancer progression but minimal toxicity.
All three patients who received CRISPR-engineered T cells in a phase 1 trial experienced cancer progression but minimal toxicity.
Historically, lung cancer rates have been higher in men, but a new study shows higher rates in women.
Each of us arrives at a given clinical crossroads with our own level of experience and comfort level.
I agree wholeheartedly with Dr. William G. Wilkoff's doubts that an increase in medical schools/students and/or foreign medical graduates is the...
A model suggests that universal girls-only HPV vaccination could prevent 61 million cases of cervical cancer.
More evidence is needed before clinicians can rely on these new tools.
Close look at the data behind these claims reveals the difficulty of establishing reliable statistics.
Recent data show that supplemental MRI screening in women with extremely dense breasts and negative screening mammograms decreases the rate of...